大型数据库与生物样本库在CKD认知障碍与痴呆研究中的应用
本文综述了阿尔茨海默病神经影像学计划、英国生物样本库等大型生物样本库研究数据如何用于加深对CKD与认知下降之间进展及相互作用的理解。各数据源各有优劣,整合多数据库数据可通过流行病学三角验证减轻单项研究局限,恰当使用这些数据有望揭示CKD与认知障碍的共同病理生物学机制。
要点
- CKD影响约10-15%成人,老年人患病率更高且认知下降风险已增加。
- CKD患者认知障碍显著更高,尤其是疾病严重阶段,透析者进展更快。
- 多数据库整合与流行病学三角验证可减轻单项研究局限。
核心结论
- 恰当使用大型生物样本库数据有望加深对CKD与认知障碍共同病理生物学的理解。
- 解决异质性数据收集与缺失数据等挑战对推进该领域研究至关重要。
研究设计与样本
- 综述探讨阿尔茨海默病神经影像学计划、英国生物样本库等大型生物样本库研究数据在CKD与认知下降研究中的应用。
主要发现
- CKD影响约10-15%的成人人群,老年人患病率更高。
- CKD患者认知障碍显著更高,尤其是疾病严重阶段,透析者进展更快。
- 大型数据源优势包括大样本量和跨不同群体、不同场景的纵向数据。
关键数值与推荐
- CKD影响约10-15%的成人人群,老年人患病率更高。
- CKD患者认知障碍显著更高,尤其是疾病严重阶段,透析者进展更快。
临床怎么用
- 利用大型生物样本库纵向数据研究CKD与认知下降的进展及相互作用。
- 整合多数据库数据以减轻单项研究局限,采用流行病学三角验证。
- 针对异质性数据收集与缺失数据采用复杂统计技术处理。
局限性
- 各数据源存在异质性数据收集方法的挑战。
- 缺失数据需使用复杂统计技术处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Research on cognitive function in individuals with chronic kidney disease (CKD) is critical due to the significant public health challenge posed by both CKD and cognitive impairment. CKD affects approximately 10-15% of the adult population, with higher prevalence in the elderly, who are already at increased risk for cognitive decline. Cognitive impairment is notably higher in CKD patients, particularly those with severe stages of the disease, and progresses more rapidly in those on dialysis. This review explores how data from large biobank studies such as the Alzheimer's Disease Neuroimaging Initiative, UK Biobank, and others could be used to enhance understanding the progression and interplay between CKD and cognitive decline. Each of these data sources has specific strengths and limitations. Strengths include large sample sizes and longitudinal data across different groups, and in different settings. Addressing limitations leads to challenges in dealing with heterogeneous data collection methods, and addressing missing data, which requires the use of sophisticated statistical techniques. Combining data from multiple databases can mitigate individual study limitations, particularly via the 'epidemiological triangulation' concept. Using such data appropriately holds immense potential to better understand the pathobiology underlying CKD and cognitive impairment. Addressing the inherent challenges with a clear strategy is crucial for advancing our understanding and improving the lives of those affected by both CKD and cognitive impairment.
引用
- Zoccali C, Mallamaci F, Rosenberg K, et al. Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia. Nephrol Dial Transplant. 2025. PMID: 40080089. doi:10.1093/ndt/gfae255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。